GENEVA, July 27 -- AVENCELL THERAPEUTICS INC. filed a patent application (IB2024/062260) for “TARGETING MODULES AGAINST CD19 AND CD20 FOR USE IN A METHOD FOR STIMULATING A REVERSED”. With publication no. WO/2025/120560, here are the other details related to the patent application:
Kind: Corrected version of pamphlet [A9]
IPC: C12N 15/11
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....